Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients

NCT02850419 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Administrative

Conditions

Interventions

Sponsor

Imunon